학술논문
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.
Document Type
Academic Journal
Author
Fiol G; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Lete I; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Nieto L; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Santaballa A; Spanish Society of Medical Oncology (Sociedad Española de Oncología Médica), 28001 Madrid, Spain.; Pla MJ; Gynecological Oncology Section of the Spanish Society of Gynecology and Obstetrics (Sección de Oncología Ginecológica de la Sociedad Española de Ginecología y Obstetricia), 28036 Madrid, Spain.; Baquedano L; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Calaf J; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Coronado P; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; de la Viuda E; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Llaneza P; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Otero B; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Sánchez-Méndez S; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Ramírez I; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.; Mendoza N; Spanish Menopause Society (Asociación Española para el Estudio de la Menopausia-AEEM), 28036 Madrid, Spain.
Source
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
Subject
Language
English
ISSN
2077-0383
Abstract
Objective: to develop eligibility criteria for use in non-gynecological cancer patients. Methods: We searched all the articles published in peer-reviewed journals up to March 2021. We utilized the PICOS standards and the following selection criteria: menopausal women with a history of non-gynecological and non-breast cancer who underwent hormone replacement therapy (HRT) using various preparations (oestrogens alone or in combination with a progestogen, tibolone, or tissue selective oestrogen complex) and different routes of administration (including oral, transdermal, vaginal, or intra-nasal). We focused on randomized controlled trials as well as relevant extension studies or follow-up reports, specifically examining recurrence and mortality outcomes. Results: Women colorectal cancer survivors who use MHT have a lower risk of death from any cause than those survivors who do not use MHT. Women who are skin melanoma survivors using MHT have a longer survival rate than non-MHT survivors. There is no evidence that women lung cancer survivors who use MHT have a different survival rate than those who do not use MHT. Conclusions: MHT is safe for women who have a history of colorectal, lung, or skin melanoma cancers.